A new prediction model for prognosis of patients with intermediate-stage HCC after conventional transarterial chemoembolization: an internally validated study

Purpose: The prognosis of patients with intermediate-stage hepatocellular carcinoma (HCC) treated by conventional TACE (cTACE) is greatly heterogeneous. This study aimed to develop a new survival prediction model to help select patients who would benefit better from cTACE treatment. Methods: We coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rong-Xin, Gan, Yu-Hong, Ge, Ning-Ling, Chen, Yi, Ma, Min, Zhang, Bo-Heng, Wang, Yan-Hong, Ye, Sheng-Long, Luo, Jian-Feng, Ren, Zheng-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856887/
https://www.ncbi.nlm.nih.gov/pubmed/31777583
http://dx.doi.org/10.7150/jca.34064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856887/
https://www.ncbi.nlm.nih.gov/pubmed/31777583
http://dx.doi.org/10.7150/jca.34064

Ejemplares similares